Laetitia Largeaud
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 05, 2026
Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.
Journal: American journal of hematology
Published: April 29, 2026
Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium.
Journal: British journal of haematology
Published: March 05, 2026
Atypical mast cells and multiple myeloma: An ambiguous alliance with diagnostic implications.
Journal: British journal of haematology
Published: February 16, 2026
A High Density of Impaired Tertiary Lymphoid Structures Is Associated with Higher Tumor Stage and Recurrence in Non-Muscle-Invasive Bladder Cancer.
Journal: Cancer immunology research
Published: January 21, 2026
Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling.
Journal: Genes and immunity
Published: January 15, 2026
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.
Journal: Nature immunology
Published: December 16, 2024
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).
Journal: Haematologica
Published: December 13, 2024
Last Updated: 09/26/2026